SMTL ID : 3f3v.1 (1 other biounit)

Kinase domain of cSrc in complex with inhibitor RL45 (Type II)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x 1BU: 1-{4-[(6-aminoquinazolin-4-yl)amino]phenyl}-3-[3-tert-butyl-1-(3-methylphenyl)-1H-pyrazol-5-yl]urea(Non-covalent)

1BU.1: 16 residues within 4Å: Chain A: L.26, A.46, E.63, M.67, L.75, E.92, Y.93, M.94, G.97, Y.135, L.146, V.155, A.156, D.157, F.158, G.159 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.26, A:E.63, A:E.63, A:L.75, A:Y.93, A:Y.135, A:L.146, A:L.146, A:V.155, A:D.157 Hydrogen bonds: A:E.63, A:E.63, A:E.63, A:M.94, A:D.157 pi-Stacking: A:F.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Getlik, M. et al., Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc. J.Med.Chem. (2009)

Release Date

2009-06-02

Peptides

Proto-oncogene tyrosine-protein kinase Src: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase Src

Related Entries With Identical Sequence